Company news
Renalytix Plc (LSE:RENX) news
Renalytix Plc news releases on 6ix. Latest, Nov 17, 2023: Publication of Annual Report 2023 & Notice of AGM
Press releases — page 3
Publication of Annual Report 2023 & Notice of AGM
November 17, 2023
Renalytix Reports Financial Results for Q1 FY2024
November 14, 2023
Notice of Results
November 7, 2023
Announcement of AGM and Publication of AR
October 30, 2023
Directorate change
October 24, 2023
US Patent Office Allows Patent Claims for IP
October 6, 2023
Medicare prices kidneyintelX.dkd at $950
October 3, 2023
Renalytix Reports Full Year Fiscal 2023 Results
September 28, 2023
Payer coverage expansion of KidneyIntelX
September 22, 2023
Appointment of Chief Business Officer
September 7, 2023
Business Update
August 21, 2023
RSU vesting for employees
August 3, 2023
Vector Pharma Middle East Distribution Agreement
July 21, 2023
Issue of Shares - Replacement
July 17, 2023
KidneyIntelX evidence presented at ADA
July 7, 2023
FDA Approves KidneyIntelX.dkd™
June 30, 2023
Presentation of Scientific Data
June 15, 2023
Financial Results for Q3 of Fiscal Year 2023
June 9, 2023
EVERSANA® partnership for KidneyIntelX
May 25, 2023
Expansion of insurance coverage for KidneyIntelX
May 22, 2023
Notice of GM and Posting of Circular
May 11, 2023
Real-World Evidence Shows KidneyIntelXT Utility
April 19, 2023
Positive Data Release at NKF Conference
April 12, 2023
Business Update - Replacement
March 27, 2023
Second Price Monitoring Extn
March 21, 2023
Statement re. Silicon Valley Bank
March 13, 2023
Director/PDMR Shareholding
February 10, 2023
RENX to Participate in the BTIG MedTech Conference
February 9, 2023
Renalytix announces a c.$20.3m private placement
February 8, 2023
Renalytix and Partners Awarded $10 Million Grant
January 26, 2023
Price Monitoring Extension
January 9, 2023
Clinical utility study data: further highlights
December 1, 2022
Results for First Quarter of Fiscal Year 2023
November 30, 2022
Publication of new real world evidence
November 29, 2022
Notice of Q1 FY23 Results
November 22, 2022
Publication of Annual Report 2022 & Notice of AGM
November 10, 2022
RENX to Present at Stifel Healthcare Conference
November 3, 2022
Renalytix Reports Full Year Fiscal 2022 Results
October 31, 2022
KidneyIntelX Medicare Update
October 25, 2022
Presentations accepted at ASN Kidney Week
October 17, 2022
Issue of shares
September 12, 2022
Renalytix to Present at H.C. Wainwright Conference
September 8, 2022
Business update
August 17, 2022
Publication of clinical utility study in The AJMC
August 8, 2022
Renalytix Reports Financial Results for Q3 of FY22
June 30, 2022
Renalytix to Report Financial Results for Q3
June 23, 2022
Mount Sinai clinical utility data
June 10, 2022
Renalytix to Present at Growth Stock Conference
June 8, 2022
Data Presentations at ADA 82nd Scientific Sessions
June 6, 2022
Successful completion of $30.0m financing package
April 8, 2022